Information card for entry 7123178
Common name
NDS-301
Chemical name
1-(3-fluorobenzyl)-2-isopropyl-1H-benzo[d]imidazole-5-carboxylic acid
Formula
C18 H17 F N2 O2
Calculated formula
C18 H17 F N2 O2
Title of publication
3D QSAR-based design and liquid phase combinatorial synthesis of 1,2-disubstituted benzimidazole-5-carboxylic acid and 3-substituted-5<i>H</i>-benzimidazo[1,2-<i>d</i>][1,4]benzodiazepin-6(7<i>H</i>)-one derivatives as anti-mycobacterial agents.
Authors of publication
Sitwala, Nikum D.; Vyas, Vivek K.; Gedia, Piyush; Patel, Kinjal; Bouzeyen, Rania; Kidwai, Saqib; Singh, Ramandeep; Ghate, Manjunath D.
Journal of publication
MedChemComm
Year of publication
2019
Journal volume
10
Journal issue
5
Pages of publication
817 - 827
a
10.0539 ± 0.0009 Å
b
10.6527 ± 0.001 Å
c
14.9435 ± 0.0014 Å
α
90°
β
90°
γ
90°
Cell volume
1600.5 ± 0.3 Å3
Cell temperature
293 K
Ambient diffraction temperature
293 K
Number of distinct elements
5
Space group number
19
Hermann-Mauguin space group symbol
P 21 21 21
Hall space group symbol
P 2ac 2ab
Residual factor for significantly intense reflections
0.0453
Weighted residual factors for all reflections included in the refinement
0.1269
Goodness-of-fit parameter for all reflections included in the refinement
1.06
Diffraction radiation wavelength
0.71075 Å
Diffraction radiation type
MoKα
Has coordinates
Yes
Has disorder
No
Has Fobs
No
For the version history of this entry, please navigate to main COD server.
The link is:
https://www.crystallography.net/7123178.html